UDI, Device Pricing, Interoperability Issues Raised In Comments To Senators
This article was originally published in The Gray Sheet
Executive Summary
In response to the Senate Finance Committee’s June request for comments on health care data sharing, the Pew Charitable Trust encouraged advances in the unique device identifier system. Industry representatives insist sharing of device price data is the wrong approach.
You may also be interested in...
Regulatory Briefs: Pre-Submission Program Final Guidance; FDA Meetings; HHS Health IT Nominations
FDA issues final guidance on its pre-submission program. The agency announced upcoming Gastroenterology and Urology Devices advisory panel meetings and a workshop for its Medical Device Epidemiology Network. More regulatory news.
Chinese Firms Up Their Game In Novel Flu Antiviral Development
Joincare Pharmaceutical and partner TaiGen Biotechnology tout preliminary Phase III results in uncomplicated acute influenza for TG-1000, a homegrown follower of Shionogi/Roche’s oral antiviral Xofluza. Novel antivirals for flu were hotly pursued by Chinese developers throughout 2023.
Quotable: Words Of Wisdom From Our Recent APAC Coverage
Scrip's APAC team selects notable quotes from recent interviews, conferences and other coverage to highlight the views of senior executives and officials on the major topics facing the biopharma sector in the region.